DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Niacor is a drug marketed by Avondale Pharms and is included in one NDA.
The generic ingredient in NIACOR is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
A generic version of NIACOR was approved as niacin by BARR on April 14th, 2005.
Recent Clinical Trials for NIACOR
Identify potential brand extensions & 505(b)(2) entrants
|University of Pennsylvania||N/A|
|Heidelberg University||Phase 1|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Avondale Pharms||NIACOR||niacin||TABLET;ORAL||040378-001||May 3, 2000||RX||No||Yes||Get Started Free||Get Started Free||Get Started Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|